News

IN3BIO gains approval for Phase I/II clinical trial

June 8, 2021 – IN3BIO Research Limited announced today that the company has received the Clinical Trial Application approval from the Bulgarian Drug Agency and Ethical Committee to initiate a Phase I/II clinical trial of its colorectal cancer vaccine in Bulgaria.